Abstract

Background: Free tissue transfer with lower abdominal flaps for autologous breast reconstruction is not suitable for all patients. The latissimus dorsi (LD) musculocutaneous flap is an alternative, effective method for both immediate and delayed breast reconstruction.

Objectives: The authors assess their experience with LD flaps for breast reconstruction, including indications for patient selection, donor site choice, aesthetic outcomes, complications, and patient satisfaction.

Methods: Charts for all patients who underwent breast reconstruction with one of three types of LD myocutaneous flaps during a three-year period at a single institution were retrospectively reviewed. Patients (n = 82) were divided into three groups: (1) 35 patients received a standard LD myocutaneous flap with implant, (2) 18 patients underwent a muscle sparing LD flap procedure with implant, and (3) 29 patients had an autologous LD flap. A questionnaire was administered to assess flap and donor site complications, aesthetic outcomes, patient satisfaction, and shoulder function.

Results: Flap complications occurred in 13 patients (15%). Donor site complications occurred in 24 patients (28%), mostly consisting of back seroma with the autologous LD flap. There was no significant difference in shoulder range of motion or muscle strength between the operated and unoperated sides. Patient satisfaction was high in all three study groups.

Conclusions: The LD is a safe, versatile, and reproducible technique for breast reconstruction. The procedure benefits from ease of flap harvesting and setting and may provide satisfactory results in diverse patients, including those for whom an abdominal flap is neither indicated nor feasible.

Level of Evidence: 4

graphic

Technique selection in breast reconstruction can be difficult because women are offered an increasingly large range of options, from implant to autologous reconstruction. Although implant-based breast reconstruction remains the most common method after mastectomy, autologous tissue may yield a superior aesthetic result.1-3 In some patients, free tissue transfer may be the best and most durable option. Autologous reconstruction is an alternative for those patients who decline implant-based reconstruction, require a salvage procedure for preoperative radiotherapy or implant failure, or may need to undergo radiation therapy.4-6

The pedicled transverse rectus abdominis musculocutaneous (TRAM) flap may provide a soft, ptotic, and natural breast mound.7 However, in an attempt to reduce the donor site morbidity of the TRAM flap, the deep inferior epigastric perforator (DIEP) flap was developed to provide the benefits of natural tissue reconstruction without sacrificing the abdominal musculature.8 Despite the favorable outcomes of free abdomen-based flap reconstructions, the procedure is not appropriate for, or desired by, all women. Patients who smoke, are extremely over- or underweight, or have a history of prior abdominal surgery may be poor candidates for lower abdominal free flaps. In addition, many women are deterred by the extensive operative time and risks with lower abdominal flap reconstruction.

The latissimus dorsi myocutaneous (LD) flap has long been an option for breast reconstruction, from the initial description in 19069,10 to its subsequent acceptance as a standard method in the 1970s.11-15 The LD flap is an effective method for immediate and delayed breast reconstruction, especially without implants or expanders, and may include only autologous tissue.16-20 It remains popular because of the simplicity of flap tissue harvest, the very reliable and consistent vascularity of the flap, its ability to provide additional prosthetic coverage, and the fact that intensive postoperative monitoring is not required. Several variations of this flap have been described: the LD myocutaneous flap with an expander or implant,9-15 the autologous or extended LD flap,16-20 and the muscle-sparing LD flap.21,22 Multiple designs and orientations of the skin paddle have also been reported.23,24

The aim of this study is to evaluate the indications, patient selection, aesthetic outcomes, and patient satisfaction of LD flap reconstruction and to analyze the goals of minimizing potential complications at the donor site, maximizing quality of the aesthetic results in a wide range of patients, and evaluating reliability and efficacy for breast reconstruction.

Methods

All patients who underwent immediate, delayed, or revision breast reconstruction with LD flaps after mastectomy between December 2007 and January 2011 in the Department of Plastic Reconstructive Surgery and Burn Unit Center at the Ospedale Niguarda in Milan, Italy, were included in this study, for a total of 82 patients. Surgery was performed in all patients by the first author (SB). Demographic, preoperative, and postoperative data were collected retrospectively by review of medical records. Patients receiving LD flap for other purposes, such as Poland syndrome correction or partial mastectomy reconstruction, were excluded. All patients were informed about the study and written informed consent was obtained before study enrollment.

The reasons for selection of the LD flap for breast reconstruction are outlined in Table 1. LD flaps were primarily indicated for patients who wished or needed to have autologous breast reconstruction but were poor candidates for TRAM or DIEP flaps or who did not wish to have free abdominal flap breast reconstruction. Again, patients were considered poor candidates for TRAM or DIEP flap procedures if they were too obese or too thin, had undergone previous abdominal surgery, or were considered at high risk for free tissue transfer because of a medical comorbidity or advanced age. Comorbid conditions included diabetes, hypertension, peripheral vascular disease, connective tissue disease, coronary artery or pulmonary disease, and previous deep venous thrombosis (Table 1).

Table 1.

Exclusion Criteria for Breast Reconstruction With Free Abdominal Tissue Transfer or Implant

CharacteristicPatients, No.
Declined free tissue transfer15
Excessively thin (BMI < 25)a14
Previous radiation therapy12
Excessively obese (BMI > 35)a9
Previous abdominal surgery7
Older (> 65 years)6
Peripheral vascular disease6
Coronary artery and/or pulmonary disease6
Connective tissue disease4
Previous deep venous thrombosis3
Total82
CharacteristicPatients, No.
Declined free tissue transfer15
Excessively thin (BMI < 25)a14
Previous radiation therapy12
Excessively obese (BMI > 35)a9
Previous abdominal surgery7
Older (> 65 years)6
Peripheral vascular disease6
Coronary artery and/or pulmonary disease6
Connective tissue disease4
Previous deep venous thrombosis3
Total82
a

BMI, body mass index (kg/m2).

Table 1.

Exclusion Criteria for Breast Reconstruction With Free Abdominal Tissue Transfer or Implant

CharacteristicPatients, No.
Declined free tissue transfer15
Excessively thin (BMI < 25)a14
Previous radiation therapy12
Excessively obese (BMI > 35)a9
Previous abdominal surgery7
Older (> 65 years)6
Peripheral vascular disease6
Coronary artery and/or pulmonary disease6
Connective tissue disease4
Previous deep venous thrombosis3
Total82
CharacteristicPatients, No.
Declined free tissue transfer15
Excessively thin (BMI < 25)a14
Previous radiation therapy12
Excessively obese (BMI > 35)a9
Previous abdominal surgery7
Older (> 65 years)6
Peripheral vascular disease6
Coronary artery and/or pulmonary disease6
Connective tissue disease4
Previous deep venous thrombosis3
Total82
a

BMI, body mass index (kg/m2).

Patients were categorized according to the three types of LD flaps utilized for total breast reconstruction: Group 1, standard latissimus dorsi musculocutaneous (S-LD) flap with implant (35 patients); Group 2, descending branch muscle-sparing latissimus dorsi myocutaneous (MS-LD) flap with implant (18 patients); and Group 3, autologous latissimus dorsi (ALD) flap (29 patients). Patients in Groups 1 and 2 underwent immediate placement of an anatomic, cohesive silicone gel implant (Memory gel Contour Profile 300 series, Mentor Inc., Santa Barbara, CA; or Natrelle Style 410, Allergan, Inc., Irvine, CA) underneath the musculocutaneous flap, without any previous tissue expander. The thoracodorsal nerve was usually dissected and sectioned in the patients in Groups 1 and 2 but spared in Group 3 to maintain muscular trophism and volume.

Data on complications, aesthetic outcomes, and patient satisfaction in these three groups were collected and reviewed. Flap complications were evaluated, including total or partial flap loss, marginal necrosis, hematoma, infection, seroma, mastectomy skin flap necrosis, implant malposition, capsular contracture, and rippling (Groups 1 and 2) and fat necrosis (> 2 cm) (Group 3). Donor site complications included delayed wound healing, wound necrosis and dehiscence, back seroma, hematoma, infection, asymmetry of the back, and impaired shoulder function. A questionnaire was administered to patients four to seven months after reconstruction to assess functional outcome and satisfaction. The questionnaire evaluated changes in the patients’ ability to perform daily living activities, hobbies, and sports; changes in job status; shoulder or scar discomfort; and aesthetic satisfaction. Satisfaction with appearance and position of the scar, symmetry of the back and silhouette, and the overall outcome of the surgery were also assessed. In the questionnaire, patients were asked to rank their satisfaction with breast reconstruction (very disappointed, disappointed, satisfied, moderately satisfied, very satisfied, or highly satisfied). Patients were then asked whether they would undergo the same reconstructive procedure again and whether they would recommend it to other women.

The Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire was also distributed at the same time as the satisfaction questionnaire.25 The DASH questionnaire scores the patient’s ability to perform tasks that are a part of activities of daily living, work, sports, and music (0 to 20, no difficulty; 21 to 40, mild difficulty; 41 to 60, moderate difficulty; 61 to 80, severe difficulty; > 80, inability to perform tasks). A postoperative physical examination was performed comparing the operated and unoperated sides. Evaluation consisted of active range of motion assessment of the shoulder and muscle strength tests. A physiotherapist performed testing on patients six months after reconstruction to evaluate their active range of motion at the shoulder joint of the operated and unoperated sides.

The two-sided Fisher exact test was applied to evaluate the significance of findings, and significance was defined by P < .05 (Database: Stata/SE version 11.2; StataCorp, Texas, USA). We calculated the incidence of each complication in the three subgroups, including incidence of flap complications in the total number of flaps performed (n = 85) and the incidence of donor site complications in the patients who had undergone the operation (n = 82).

Results

There were 85 LD flaps performed on 82 patients in this series (three patients underwent bilateral flap procedures). The average patient age was 49 years (range, 32 to 70 years). The average follow-up time was 21 months (range, three to 39 months). LD reconstructions represented 28% of overall breast reconstructions in the authors’ practice during the study period. Reconstruction was immediate in 26 patients (32%), including 11 patients who required salvage mastectomy for cancer recurrence after breast lumpectomy surgery and radiotherapy. Reconstruction was delayed after previous mastectomy in 41 patients (50%). In 14 patients (17%), LD flap reconstruction was performed to revise a previous expander/implant reconstruction because of implant extrusion, capsular contracture (CC), and/or unsatisfactory aesthetics. Reconstruction with an LD flap was performed in one patient (1%) for failed DIEP flap replacement. Most patients underwent a procedure with either an S-LD flap with implant or an ALD flap (Table 2). Most patients had contralateral procedures—including reduction mammaplasty, mastopexy with or without implant, or augmentation mammaplasty—to improve breast shape, symmetry, and aesthetic outcome.

Table 2.

Complications Observed With Latissimus Dorsi Flap Reconstruction of the Breasta

No. (%)bS-LD + ImplantMS-LD + ImplantALD
Patients82351829
Flap procedures85371929
Flap-related complicationsc
 Mastectomy skin flap necrosis5 (6)212
 Minor skin paddle necrosis3 (4)210
 Implant malposition2 (2)11NA
 Liponecrosis2 (2)NANA2
 Rippling1 (1)10NA
 Total13 (15)634
Donor site complicationsd
 Seromae15 (18)2013
 Delayed wound healing3 (4)300
 Wound necrosis and dehiscencee3 (4)003
 Hematoma2 (2)101
 Minor wound dehiscence1 (1)010
 Total24 (28)6117
No. (%)bS-LD + ImplantMS-LD + ImplantALD
Patients82351829
Flap procedures85371929
Flap-related complicationsc
 Mastectomy skin flap necrosis5 (6)212
 Minor skin paddle necrosis3 (4)210
 Implant malposition2 (2)11NA
 Liponecrosis2 (2)NANA2
 Rippling1 (1)10NA
 Total13 (15)634
Donor site complicationsd
 Seromae15 (18)2013
 Delayed wound healing3 (4)300
 Wound necrosis and dehiscencee3 (4)003
 Hematoma2 (2)101
 Minor wound dehiscence1 (1)010
 Total24 (28)6117
a

S-LD, standard latissimus dorsi musculocutaneous; MS-LD, muscle-sparing latissimus dorsi myocutaneous; ALD, autologous latissimus dorsi; NA, not available.

b

Reported as percentage of reconstruction procedures.

c

There were no cases of total or partial flap loss, flap hematoma, flap seroma, capsular contracture, or implant exposure (data were not available about capsular contracture or implant exposure with ALD flap).

d

There were no cases of donor site infection, asymmetry, or impaired shoulder function with any of the three flap procedures.

e

Significant differences were noted between the three latissimus dorsi flap procedures in frequency of donor site seroma (P < .005) and wound necrosis and dehiscence (P < .05); there were no other significant differences in flap-related or donor site complications between the three latissimus dorsi flap procedures.

Table 2.

Complications Observed With Latissimus Dorsi Flap Reconstruction of the Breasta

No. (%)bS-LD + ImplantMS-LD + ImplantALD
Patients82351829
Flap procedures85371929
Flap-related complicationsc
 Mastectomy skin flap necrosis5 (6)212
 Minor skin paddle necrosis3 (4)210
 Implant malposition2 (2)11NA
 Liponecrosis2 (2)NANA2
 Rippling1 (1)10NA
 Total13 (15)634
Donor site complicationsd
 Seromae15 (18)2013
 Delayed wound healing3 (4)300
 Wound necrosis and dehiscencee3 (4)003
 Hematoma2 (2)101
 Minor wound dehiscence1 (1)010
 Total24 (28)6117
No. (%)bS-LD + ImplantMS-LD + ImplantALD
Patients82351829
Flap procedures85371929
Flap-related complicationsc
 Mastectomy skin flap necrosis5 (6)212
 Minor skin paddle necrosis3 (4)210
 Implant malposition2 (2)11NA
 Liponecrosis2 (2)NANA2
 Rippling1 (1)10NA
 Total13 (15)634
Donor site complicationsd
 Seromae15 (18)2013
 Delayed wound healing3 (4)300
 Wound necrosis and dehiscencee3 (4)003
 Hematoma2 (2)101
 Minor wound dehiscence1 (1)010
 Total24 (28)6117
a

S-LD, standard latissimus dorsi musculocutaneous; MS-LD, muscle-sparing latissimus dorsi myocutaneous; ALD, autologous latissimus dorsi; NA, not available.

b

Reported as percentage of reconstruction procedures.

c

There were no cases of total or partial flap loss, flap hematoma, flap seroma, capsular contracture, or implant exposure (data were not available about capsular contracture or implant exposure with ALD flap).

d

There were no cases of donor site infection, asymmetry, or impaired shoulder function with any of the three flap procedures.

e

Significant differences were noted between the three latissimus dorsi flap procedures in frequency of donor site seroma (P < .005) and wound necrosis and dehiscence (P < .05); there were no other significant differences in flap-related or donor site complications between the three latissimus dorsi flap procedures.

Flap complications occurred in 13 reconstructions (15%; Table 2). There were no flap failures or returns to surgery for flap-related problems in any of the patients. Flap-related complications included mastectomy skin flap necrosis, minor skin paddle tip necrosis, implant malposition, liponecrosis, and rippling (the latter was in one slim patient 13 months postoperatively; Table 2). In one of the two patients who experienced liponecrosis, there had been severe intraoperative venous congestion because of occlusion of the thoracodorsal vein during previous axillary dissection, even though the flow was restored by vein graft. There were no significant differences in flap complications between the three groups (Table 2). Donor site complications were noted in 24 reconstructions (28%), most commonly seroma after ALD reconstruction (Table 2).

All 82 patients returned the questionnaires (response rate, 100%). The mean DASH scores showed that patients had no difficulty with activities of daily living (mean score, 7.8), work status (mean, 11.3), or sports and music (mean, 19.0). There was no change in the patients’ ability to perform hobby or sport-related activities in 72 patients (88%), and 76 patients (93%) perceived no permanent functional impairment of the shoulder postoperatively. Patients did not perceive any differences in muscle strength or range of motion between the operated and unoperated sides. Based on physiotherapist assessment, there was a difference of ≤ 10° between the ranges of flexion, extension, and external rotation between the operated and unoperated shoulders in 11 patients (13%). Seventy-three patients (89%) rated the appearance of the scar as good or very good. Patient satisfaction was very high for all three types of reconstruction in breast shape, size, appearance, position of back scar, and symmetry of the back. Of all the patients, 74 (90%) reported that they would have elected to undergo the procedure again based on their experience and aesthetic outcome.

Discussion

The aim of this systematic review of LD flap breast reconstruction was to evaluate this procedure as an option for patients seeking breast reconstruction. The present findings showed that LD flap reconstruction provided satisfactory results for most patients with few complications.

The LD flap has several important advantages. The flap is very well vascularized, versatile, safe, reliable, and has a success rate of more than 99%. The procedure is suitable for high-risk patients, including those who smoke, are obese, have diabetes, or are older. The LD flap may be employed for immediate or delayed reconstruction, unilateral and bilateral cases, cases in which an implant is not indicated or desired because of radiotherapy,6 cases in which the chest wall tissues are unsuitable for tissue expansion, or cases in which additional soft tissue requirements are present (Figure 1). This technique is also suitable for chest wall reconstruction26 or resurfacing in cases of advanced or recurrent breast cancer. It also can be applied for partial breast reconstruction, backup flap after abdominal flap loss, or correction of breast hypoplasia in Poland syndrome. Other indications include breast reconstruction in patients who are not suitable for TRAM/DIEP flaps (Figure 2) or who need conversion of failed implant reconstruction. The LD flap technique is contraindicated in very few patients, such as patients with previous thoracotomy and division of the muscle or damage to the thoracodorsal vessels.

(A) This 48-year-old woman had undergone prior right nipple-sparing mastectomy and left radical mastectomy at another hospital. (B) Two weeks after right descending-branch muscle-sparing latissimus dorsi (MS-LD) musculocutaneous flap and left standard latissimus dorsi (S-LD) flap. The patient was too thin for an abdominal free flap.
Figure 1.

(A) This 48-year-old woman had undergone prior right nipple-sparing mastectomy and left radical mastectomy at another hospital. (B) Two weeks after right descending-branch muscle-sparing latissimus dorsi (MS-LD) musculocutaneous flap and left standard latissimus dorsi (S-LD) flap. The patient was too thin for an abdominal free flap.

(A) This 43-year-old patient had undergone previous left radical mastectomy. (B) Six months after left autologous latissimus dorsi (ALD) flap breast reconstruction and contralateral reduction mammaplasty. The patient was too obese for transverse rectus abdominis musculocutaneous (TRAM) or deep inferior epigastric perforator (DIEP) flaps.
Figure 2.

(A) This 43-year-old patient had undergone previous left radical mastectomy. (B) Six months after left autologous latissimus dorsi (ALD) flap breast reconstruction and contralateral reduction mammaplasty. The patient was too obese for transverse rectus abdominis musculocutaneous (TRAM) or deep inferior epigastric perforator (DIEP) flaps.

Even if the amount of skin that can be provided by the LD flap is less than that of an abdominal flap, the dorsal skin palette can usually compensate for a large cutaneous defect, and the skin can be completely de-epithelialized and buried to avoid a patch effect or partially preserved for reconstruction of the nipple-areola complex after a skin-sparing mastectomy.27 A recent report of a sophisticated procedure may expand the candidacy for DIEP flap breast reconstruction in thin patients, making use of the entire abdominal donor volume; in this procedure, two DIEP free flaps are stacked and combined in a layered fashion with microsurgical sequential linkage of the two pedicles and resultant flow-through from recipient internal mammary vessels.28 Nevertheless, the LD flap can still provide an aesthetically satisfactory result in thin patients for whom the amount of abdominal tissue is inadequate and precludes abdominal tissue transfer.

The low incidence of seroma after S-LD and MS-LD reconstruction in this study was likely attributable to the use of glue, quilting sutures, and minimal dead space from the limited undermining of the skin flap. Seroma was more frequent in the ALD flap group compared with the other two groups (Table 2), despite quilting stitches and fibrin glue, most likely because of wide and extensive undermining of tissue with the ALD flap procedure. Furthermore, the ALD flap may include a major volume of fat, which may give bulk to the breast without the addition of a prosthesis and may yield a reconstructed breast with a soft, natural consistency and which gains deep sensitivity after several months (Figure 3). Spontaneous return of sensitivity after LD flap reconstruction, with integration of the reconstructed breast into the patient’s body image, has been reported in several studies.29-31 The ALD flap also represents a viable option over free abdominal tissue transfer in morbidly obese patients, for whom free abdomen-based flap reconstruction of the breast has a higher risk of total flap loss and delayed abdominal wound healing.32

(A) This 52-year-old woman presented for breast reconstruction. She underwent a delayed left autologous latissimus dorsi (ALD) flap breast reconstruction and contralateral reduction mammaplasty. (B) One year after left nipple reconstruction.
Figure 3.

(A) This 52-year-old woman presented for breast reconstruction. She underwent a delayed left autologous latissimus dorsi (ALD) flap breast reconstruction and contralateral reduction mammaplasty. (B) One year after left nipple reconstruction.

The LD flap is also a highly effective tool in dealing with the many difficult situations observed with the irradiated breast. These include correction of CC after irradiation of a tissue expander, immediate reconstruction after mastectomy following failed breast conservation therapy, delayed reconstruction after mastectomy and radiotherapy, revision of an unsatisfactory implant reconstruction in a radiated breast, and reconstruction of a partial breast defect after breast conservation therapy (Figures 4, 5).

(A) This 40-year-old woman presented with recurrent right breast cancer after lumpectomy and radiotherapy. (B) Six months after right muscle-sparing latissimus dorsi (MS-LD) musculocutaneous flap and contralateral augmentation mastopexy.
Figure 4.

(A) This 40-year-old woman presented with recurrent right breast cancer after lumpectomy and radiotherapy. (B) Six months after right muscle-sparing latissimus dorsi (MS-LD) musculocutaneous flap and contralateral augmentation mastopexy.

(A) This 53-year-old woman had right breast expander extrusion after right radical mastectomy and radiotherapy. (B) Eight months after right standard latissimus dorsi (S-LD) myocutaneous flap with implant (Natrelle® 410 MM cohesive gel implant, 245 cc; Allergan, Santa Barbara, CA) and left breast reduction to achieve symmetry. The patient was not a good candidate for a deep inferior epigastric perforator (DIEP) flap because of medical comorbidities.
Figure 5.

(A) This 53-year-old woman had right breast expander extrusion after right radical mastectomy and radiotherapy. (B) Eight months after right standard latissimus dorsi (S-LD) myocutaneous flap with implant (Natrelle® 410 MM cohesive gel implant, 245 cc; Allergan, Santa Barbara, CA) and left breast reduction to achieve symmetry. The patient was not a good candidate for a deep inferior epigastric perforator (DIEP) flap because of medical comorbidities.

Prior radiation therapy to the chest may have a detrimental effect on the recipient vessels and may affect microvascular success. In recent studies, prereconstruction radiation therapy increased the frequency of vascular complications in free flap breast reconstruction.33,34 To minimize microvascular complications and optimize outcomes in free flap breast reconstruction in patients undergoing postmastectomy radiation, a delay interval of more than 12 months should be observed. However, this delay is not required with LD flap reconstruction of the breast. Some of the prior irradiated patients received breast reconstruction a few months after the completion of radiotherapy. Although LD flap reconstruction is a major operation, it is less complex than free tissue transfer and does not require microsurgical skills; intensive, sophisticated, and costly postoperative flap monitoring (as with free flaps);35-38 or any preoperative CT scan to evaluate the vascular anatomy.39-43 Perioperative cost is less with LD flap reconstruction than free tissue transfer because physical examination before surgery is usually sufficient to test the function of the LD muscle and, if necessary, color Doppler studies may be sufficient to establish the continuity of the thoracodorsal vessels. The LD flap alone or combined with an implant also represents a safe and reliable alternative in patients with a failed microsurgical breast reconstruction, because it is a relatively simple procedure with low morbidity, especially in patients with coagulation disorders that may contribute to free flap failure.44

Sacrifice of the LD muscle is very well tolerated in most patients, functionally-speaking, and any deficit usually affects very few specific activities such as rowing or mountain climbing. Patients have few complaints after LD muscle transfer and functional sequelae are minimized by compensation with the teres major muscle.45-49 Therefore, as noted in the present study, the LD flap minimally impairs shoulder function, with little detectable change in range of motion, muscular strength, and function of the donor shoulder. Axillary dissection for removal of lymph nodes can be responsible for more limitation in shoulder function than the LD flap reconstruction. With the help of a physiotherapist, we demonstrated that most patients showed no objective limitation in muscular function and all patients reported that they experienced no limitation in daily life.

Donor site seroma may occur after 6% to 56% of S-LD flaps and 70% to 80% of ALD flaps.19,50-53 Numerous treatments and preventive measures have been described to decrease this problem, including quilting sutures, fibrin sealant, endoscopic harvest, long-term distant exit drainage, pressure dressings, and avoidance of electrocautery for dissection.54-60 Quilting sutures combined with fibrin sealant were used in all three types of LD flap procedures in the present study, with few postoperative seromas compared with the experience reported by others (Table 2).19,53 Other authors have shown new risk factors for donor site seroma formation after LD flap reconstruction, including antidepressant drugs (selective serotonin reuptake inhibitors) and low postoperative calcium levels, in addition to well-established risk factors such as age, obesity, and surgical technique.61

In the present study, patient satisfaction was very high, confirming that the LD flap may provide an excellent breast reconstruction in diverse patients. The only disadvantage observed was the high incidence of back seroma in the ALD flap group, which may limit the choice of this type of reconstruction. However, various preventive maneuvers and treatments can be added to decrease and control this complication; these instances of seroma can be treated on an outpatient basis and have a lower detrimental effect on the patient compared with free flap loss or an abdominal bulge or hernia. This disadvantage is mitigated by the many advantages and benefits that make the LD flap a valuable option for breast reconstruction, especially in patients not suited for free abdominal flaps.

Conclusions

This study has confirmed the clinical versatility, reliability, and selection guidelines for use of the LD flap in breast reconstruction. This flap is simple to harvest and is an excellent alternative to other procedures, since it provides satisfactory, consistent, and reliable results. The success of the procedure depends on patient selection, careful intraoperative management, and adequate postoperative care.

Disclosures

The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.

Funding

The authors received no financial support for the research, authorship, and publication of this article.

References

1.

Kroll
SS
Baldwin
B
.
A comparison of outcomes using three different methods of breast reconstruction
.
Plast Reconstr Surg
1992
;
90
:
455
-
462
.

2.

Serletti
J
.
Breast reconstruction with the TRAM flap: pedicled and free
.
J Surg Oncol
2006
;
94
:
532
-
537
.

3.

Craft
RO
Colakoglu
S
Curtis
MS
et al. .
Patient satisfaction in unilateral and bilateral breast reconstruction
.
Plast Reconstr Surg
2011
;
127
:
1417
-
1424
.

4.

Evans
GR
Schustermann
MA
Kroll
SS
et al. .
Reconstruction and the radiated breast: is there a role for implants?
Plast Reconstr Surg
1995
;
96
:
1111
-
1115
.

5.

Spear
SL
Onyewe
C
.
Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications
.
Plast Reconstr Surg
2000
;
105
:
930
-
942
.

6.

Spear
SL
Boehmler
JH
Taylor
NS
Prada
C
.
The role of the latissimus dorsi flap in reconstruction of the irradiated breast
.
Plast Reconstr Surg
2007
;
119
:
1
-
9
.

7.

Hartrampf
CR
Jr
Scheflan
M
Blach
PW
.
Breast reconstruction with a transverse abdominal island flap
.
Plast Reconstr Surg
1982
;
69
:
216
-
225
.

8.

Allen
RJ
Treece
P
.
Deep inferior epigastric perforator flap for breast reconstruction
.
Ann Plast Surg
1994
;
32
:
32
-
38
.

9.

Tansini
I
.
Sopra il mio nuovo processo di amputazione della mammella
.
Gazz Med Ital
1906
;
57
:
141
.

10.

Maxwell
GP
.
Iginio Tansini and the origin of the latissimus dorsi musculocutaneous flap
.
Plast Reconstr Surg
1980
;
65
:
686
-
692
.

11.

Olivari
N
.
The latissimus flap
.
Br J Plast Surg
1976
;
29
:
126
-
128
.

12.

Schneider
WJ
Hill
HL
Brown
RG
.
Latissimus dorsi myocutaneous flap for breast reconstruction
.
Br J Plast Surg
1977
;
30
:
277
-
281
.

13.

Muhlbauer
W
Olbrisch
R
.
The latissimus dorsi myocutaneous flap for breast reconstruction
.
Chir Plast
1977
;
4
:
27
.

14.

Bostwick
J
III
Scheflan
M
.
The latissimus dorsi musculocutaneous flap: a one-stage breast reconstruction
.
Clin Plast Surg
1980
;
7
:
71
-
78
.

15.

Maxwell
GP
.
Latissimus dorsi breast reconstruction: an aesthetic assessment
.
Clin Plast Surg
1981
;
8
:
373
-
387
.

16.

Hokin
JAB
Silfverskiold
KL
.
Breast reconstruction without an implant: results and complications using an extended latissimus dorsi flap
.
Plast Reconstr Surg
1987
;
79
:
58
-
66
.

17.

McCraw
JB
Papp
C
Edwards
A
McMellin
A
.
The autogenous latissimus breast reconstruction
.
Clin Plast Surg
1994
;
21
:
279
-
288
.

18.

Papp
C
McCraw
JB
.
Autogenous latissimus breast reconstruction
.
Clin Plast Surg
1998
;
25
:
261
-
266
.

19.

Delay
E
Gounot
N
Bouillot
A
Zlatoff
P
Rivoire
M
.
Autologous latissimus breast reconstruction: a 3-year clinical experience with 100 patients
.
Plast Reconstr Surg
1998
;
102
:
1461
-
1478
.

20.

Chang
DW
Youssef
A
Cha
S
Reece
GP
.
Autologous breast reconstruction with the extended latissimus dorsi flap
.
Plast Reconstr Surg
2002
;
110
:
751
-
759
.

21.

Saint-Cyr
M
Nagarkar
P
Schaverien
M
Dauwe
P
Wong
C
Rohrich
RJ
.
The pedicled descending branch muscle-sparing latissimus dorsi flap for breast reconstruction
.
Plast Reconstr Surg
2009
;
123
:
13
-
24
.

22.

Brackley
PTH
Mishra
A
Sigaroudina
M
Iqbal
A
.
Modified muscle sparing latissimus dorsi with implant for total breast reconstruction-Extending the boundaries
.
J Plast Reconstr Aesthet Surg
2010
;
63
:
1495
-
1502
.

23.

McCraw
JB
Papp
CT
.
Latissimus dorsi myocutaneous flap: “fleur de lis” reconstruction
. In
Hartrampf
CR
, ed.
Breast Reconstruction With Living Tissue
.
Norfolk, VA
:
Hampton Press
;
1991
:
221
.

24.

Bailey
S
Saint-Cyr
M
Zhang
K
et al. .
Breast reconstruction with the latissimus dorsi flap: women’s preference for scar location
.
Plast Reconstr Surg
2010
;
126
:
358
-
365
.

25.

Hudak
PL
Amadio
PC
Bombardier
C
.
The Upper Extremity Collaborative Group (UECG) development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand)
.
Am J Ind Med
.
1996
;
29
:
602
-
608
.

26.

Maia
M
Oni
G
Wong
C
Saint-Cyr
M
.
Anterior chest wall reconstruction with a low skin paddle pedicled latissimus dorsi flap: a novel flap design
.
Plast Reconstr Surg
2011
;
127
:
1206
-
1211
.

27.

Deay
E
Mojallal
A
Vasseur
C
Delaporte
T
.
Immediate nipple reconstruction during immediate autologous latissimus breast reconstruction
.
Plast Reconstr Surg
2006
;
118
:
1303
-
1312
.

28.

DellaCroce
FJ
Sullivan
SK
Trahan
C
.
Stacked deep inferior epigastric perforator flap breast reconstruction: a review of 110 flaps in 55 cases over 3 years
.
Plast Reconstr Surg
2011
;
127
:
1093
-
1099
.

29.

Lehman
NC
Gumener
R
Montandon
D
.
Sensibility and cutaneous reinnervation after breast reconstruction with musculocutaneous flaps
.
Ann Plast Surg
1991
;
26
:
325
-
327
.

30.

Peltoniemi
H
Asko-Selijavaara
S
Harma
M
Sundell
B
.
Latissimus dorsi breast reconstruction: long term results and return of sensibility
.
Scand J Plast Reconstr Surg Hand Surg
1993
;
27
:
127
-
131
.

31.

Delay
E
Jorquera
F
Lucas
R
Lopez
R
.
Sensitivity of breasts reconstructed with the autologous latissimus dorsi flap
.
Plast Reconstr Surg
2000
;
106
:
302
-
309
.

32.

Jandali
S
Nelson
JA
Sonnad
S
et al. .
Breast reconstruction with free tissue transfer from the abdomen in the morbidly obese
.
Plast Reconstr Surg
2011
;
127
:
2206
-
2213
.

33.

Fosnot
J
Fischer
JP
Smartt
JM
Jr
et al. .
Does previous chest wall irradiation increase vascular complications in free autologous breast reconstruction?
Plast Reconstr Surg
2011
;
127
:
496
-
504
.

34.

Baumann
DP
Crosby
MA
Selber
JC
et al. .
Optimal timing of delayed free lower abdominal flap breast reconstruction after postmastectomy radiation therapy
.
Plast Reconstr Surg
2011
;
127
:
1100
-
1106
.

35.

Colwell
AS
Wright
L
Karanas
Y
.
Near-infrared spectroscopy measures tissue oxygenation in free flaps for breast reconstruction
.
Plast Reconstr Surg
2008
;
121
:
344e
-
345e
.

36.

Rozen
WM
Chubb
D
Whitaker
IS
Acosta
R
.
The efficacy of postoperative monitoring: a single surgeon comparison of clinical monitoring and the implantable Doppler probe in 547 consecutive free flaps
.
Microsurgery
2010
;
30
:
105
-
110
.

37.

Whitaker
IS
Rozen
WM
Chubb
D
et al. .
Postoperative monitoring of free flaps in autologous breast reconstruction: a multicenter comparison of 398 flaps using clinical monitoring, microdialysis, and the implantable Doppler probe
.
J Reconstr Microsurg
2010
;
26
:
409
-
416
.

38.

Lin
SJ
Nguyen
M
Chen
C
et al. .
Tissue oxymetry monitoring in microsurgical breast reconstruction decreases flap loss and improve rate of flap salvage
.
Plast Reconstr Surg
2011
;
127
:
1080
-
1085
.

39.

Alonso-Burgos
A
Garcia-Tutor
E
Bastarrika
G
Cano
D
Martinez-Cuesta
A
Pina
LJ
.
Preoperative planning of deep inferior epigastric artery perforator flap reconstruction with multislice-CT angiography: imaging findings and initial experience
.
J Plast Reconstr Aesthet Surg
2006
;
59
:
585
-
593
.

40.

Masia
J
Clavero
JA
Larranaga
JR
Alomar
X
Pons
G
Serret
P
.
Multidetector-row computer tomography in the planning of abdominal perforator flaps
.
J Plast Reconstr Aesthet Surg
2006
;
59
:
594
-
599
.

41.

Rozen
WM
Phillips
TJ
Ashton
MW
Stella
DL
Gibson
RN
Taylor
GI
.
Preoperative imaging dor DIEA perforator flaps: a comparative study of computed tomographic angiography and Doppler ultrasound
.
Plast Reconstr Surg
2008
;
121
:
9
-
16
.

42.

Casey
WJ
III
Chew
RT
Rebecca
AM
Smith
A
Collins
JM
Pockaj
BA
.
Advantages of preoperative computed tomography in deep inferior epigastric artery perforator flap breast reconstruction
.
Plast Reconstr Surg
2009
;
123
:
1148
-
1155
.

43.

Wong
C
Saint-Cyr
M
Arbique
G
Becker
S
et al. .
Three-and four-dimensional computed tomography angiographic studies of commonly used abdominal flaps in breast reconstruction
.
Plast Reconstr Surg
2009
;
124
:
18
-
27
.

44.

Hamdi
M
Andrades
P
Thiessen
F
et al. .
Is a second free flap still an option in a failed free flap breast reconstruction?
Plast Reconstr Surg
2010
;
126
:
375
-
384
.

45.

Brumback
RJ
McBride
MS
Ortolani
NC
.
Functional evaluation of the shoulder after transfer of the vascularised latissimus dorsi muscle
.
J Bone Joint Surg Br
1992
;
74
:
377

46.

Laitung
JKG
Peck
F
.
Shoulder function following the loss of the latissimus dorsi muscle
.
Br J Plast Surg
1985
;
38
:
375
-
379
.

47.

Russell
RC
Pribaz
J
Zook
EG
Leighton
WD
Eriksson
E
Smith
CJ
.
Functional evaluation of latissimus dorsi donor site
.
Plast Reconstr Surg
1986
;
78
:
336
-
344
.

48.

Fraulin
FOG
Louie
G
Zorrilla
L
Tilley
W
.
Functional evaluation of the shoulder following latissimus dorsi muscle transfer
.
Ann Plast Surg
1995
;
35
:
349
-
355
.

49.

Adams
WP
Jr
Lipschitz
AH
Ansari
M
Kenkel
JM
Rorich
RJ
.
Functional donor site morbidity following latissimus dorsi flap transfer
.
Ann Plast Surg
2004
;
53
:
6
-
11
.

50.

Titley
OG
Spyrou
GE
Fatah
MF
.
Preventing seroma in the latissimus dorsi flap donor site
.
Br J Plast Surg
1997
;
50
:
106
-
109
.

51.

Roy
MK
Shrotia
S
Holcombe
C
Webster
DJ
Hughes
LE
Mansel
RE
.
Complications of latissimus dorsi myocutaneous flap breast reconstruction
.
Eur J Surg Oncol
1998
;
24
:
162
-
165
.

52.

Schwabegger
A
Ninkovic
M
Brenner
E
Anderl
H
.
Seroma as a common donor site morbidity after harvesting the latissimus dorsi flap: observations on cause and prevention
.
Ann Plast Surg
1997
;
38
:
594
-
597
.

53.

Clough
KB
Louis-Sylvestre
C
Fitoussi
A
Couturaud
B
Nos
C
.
Donor site sequelae after autologous breast reconstruction with an extended latissimus dorsi flap
.
Plast Reconstr Surg
2002
;
109
:
1904
-
1911
.

54.

Tomita
K
Yano
K
Matsuoka
T
Matsuda
K
Takada
A
Hosokawa
K
.
Postoperative seroma formation in breast reconstruction with latissimus dorsi flaps: a retrospective study of 174 consecutive cases
.
Ann Plast Surg
2007
;
59
:
149
-
151
.

55.

Daltrey
I
Thomson
H
Hussien
M
Krishna
K
Rayter
Z
Winters
ZE
.
Randomized clinical trial of the effect of quilting latissimus dorsi flap donor site on seroma formation
.
Br J Plast Surg
2006
;
93
:
825
-
830
.

56.

Lam
DG
Choudhary
S
Cadier
MA
.
Latissimus dorsi donor-site quilting: less is more?
Plast Reconstr Surg
2000
;
105
:
2271
.

57.

Rios
JL
Pollock
T
Adams
WP
Jr
.
Progressive tension sutures to prevent seroma formation after latissimus dorsi harvest
.
Plast Reconstr Surg
2003
;
112
:
1779
-
1783
.

58.

Munhoz
AM
Aldrighi
CM
.
Prediction of postoperative seroma after latissimus dorsi breast reconstruction
.
Plast Reconstr Surg
2006
;
118
:
567
.

59.

Randolph
LC
Barone
J
Angelats
J
Dado
DV
Vandevender
DK
Shoup
M
.
Prediction of postoperative seroma after latissimus dorsi breast reconstruction
.
Plast Reconstr Surg
2005
;
116
:
1287
-
1290
.

60.

Weinrach
JC
Cronin
ED
Smith
BK
Collins
DR
Jr
Cohen
BE
.
Preventing seroma in the latissimus dorsi flap donor site with fibrin sealant
.
Ann Plast Surg
2004
;
53
:
12
-
16
.

61.

Gruber
S
Whitworth
AB
Kemmler
G
Papp
C
.
New risk factors for donor site seroma formation after latissimus dorsi flap breast reconstruction: 10-year period outcome analysis
.
J Plast Reconstr Aesthet Surg
2011
;
64
:
69
-
74
.